{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Aripiprazole+tablet%2C+30+mg", "query": { "intervention": "Aripiprazole tablet, 30 mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Aripiprazole+tablet%2C+30+mg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-28T16:21:51.164Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00338273", "title": "A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2006-12", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2013-11-08", "last_synced_at": "2026-09-28T16:21:51.164Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00338273" }, { "nct_id": "NCT00683852", "title": "A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Aripiprazole 5mg", "type": "DRUG" }, { "name": "Aripiprazole 2mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 225, "start_date": "2008-09", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2017-07-19", "last_synced_at": "2026-09-28T16:21:51.164Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00683852" }, { "nct_id": "NCT00321516", "title": "Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2006-07", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2013-11-08", "last_synced_at": "2026-09-28T16:21:51.164Z", "location_count": 4, "location_summary": "Philadelphia, Pennsylvania • Austin, Texas • Bellaire, Texas + 1 more", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Austin", "state": "Texas" }, { "city": "Bellaire", "state": "Texas" }, { "city": "Desota", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00321516" }, { "nct_id": "NCT00101569", "title": "Aripiprazole Oral Acceptability Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2004-03", "completion_date": "2005-03", "has_results": false, "last_update_posted_date": "2013-11-08", "last_synced_at": "2026-09-28T16:21:51.164Z", "location_count": 7, "location_summary": "Anaheim, California • National City, California • North Miami Beach, Florida + 4 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "North Miami Beach", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Staten Island", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00101569" }, { "nct_id": "NCT00261443", "title": "A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Lithium or Valproate with placebo (PBO)", "type": "DRUG" }, { "name": "Lithium or Valproate with Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1270, "start_date": "2005-09", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2023-04-18", "last_synced_at": "2026-09-28T16:21:51.164Z", "location_count": 29, "location_summary": "Tuscaloosa, Alabama • Anaheim, California • Cerritos, California + 24 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00261443" }, { "nct_id": "NCT00110461", "title": "Aripiprazole in Children and Adolescents With Bipolar I Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 296, "start_date": "2005-03", "completion_date": "2007-02", "has_results": true, "last_update_posted_date": "2012-05-21", "last_synced_at": "2026-09-28T16:21:51.164Z", "location_count": 53, "location_summary": "Scottsdale, Arizona • Little Rock, Arkansas • National City, California + 50 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "National City", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00110461" }, { "nct_id": "NCT00845026", "title": "A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "LY2140023", "type": "DRUG" }, { "name": "aripiprazole", "type": "DRUG" }, { "name": "olanzapine", "type": "DRUG" }, { "name": "risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Denovo Biopharma LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 261, "start_date": "2009-03", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2022-11-08", "last_synced_at": "2026-09-28T16:21:51.164Z", "location_count": 11, "location_summary": "Escondido, California • Garden Grove, California • Washington D.C., District of Columbia + 8 more", "locations": [ { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Hoffman Estates", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00845026" }, { "nct_id": "NCT00802100", "title": "Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Olanzapine", "type": "DRUG" }, { "name": "Perphenazine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Simvastatin", "type": "DRUG" }, { "name": "Benztropine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Mental Health (NIMH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 21, "start_date": "2008-12", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2013-02-08", "last_synced_at": "2026-09-28T16:21:51.164Z", "location_count": 13, "location_summary": "Colton, California • Palo Alto, California • New Haven, Connecticut + 10 more", "locations": [ { "city": "Colton", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00802100" }, { "nct_id": "NCT00277212", "title": "A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Lamotrigine + Aripiprazole", "type": "DRUG" }, { "name": "Lamotrigine + Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1169, "start_date": "2005-12-01", "completion_date": "2009-07-01", "has_results": true, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-09-28T16:21:51.164Z", "location_count": 62, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Anaheim, California + 55 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00277212" }, { "nct_id": "NCT00097266", "title": "Study of Aripiprazole in Patients With Acute Bipolar Mania", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 615, "start_date": "2004-12", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2013-11-08", "last_synced_at": "2026-09-28T16:21:51.164Z", "location_count": 15, "location_summary": "Anaheim, California • Cerritos, California • Garden Grove, California + 12 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Pico Rivera", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00097266" } ] }